Publicaciones › Edema macular diabético y sus tratamientos
Optical Coherence Tomography in the Management of Diabetic Macular Edema
Tomografía de Coherencia Óptica en el Manejo del Edema Macular Diabético
| Año | 2014 |
|---|---|
| Fuente | ESASO course series |
| Tipo | book-chapter |
| Autores (2) | Ali Erginay, Pascale Massin |
| Posición de Erginay | 1 de 2 |
| Citas | 2 (OpenAlex) |
| Enlaces | DOI 10.1159/000355918 · OpenAlex |
| Líneas | Edema macular diabético y sus tratamientos Retinopatía diabética: clínica, función y progresión Imagen retiniana: OCT, OCT-angiografía y ultra-gran campo |
En pocas palabras
Se estudió el uso de la tomografía de coherencia óptica (OCT) en el manejo del edema macular diabético. La OCT permite diagnosticar y monitorear el edema macular de manera no invasiva, proporcionando información detallada sobre los cambios estructurales en la retina. Esto permite una evaluación más precisa del tratamiento y su eficacia.
Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.
Resumen original
Today, optical coherence tomography (OCT) has become the first imaging technique in the assessment and management of diabetic macular edema (DME). OCT can diagnose macular edema noninvasively even at a very early stage. OCT is able to demonstrate basic structural changes of the retina from DME: retinal swelling, cystoid edema, serous retinal detachment, vitreoretinal traction, photoreceptor layer status and atrophy. Especially the new-generation spectral domain (SD)-OCT with more rapid acquisition and the higher image resolution has new functions like eye tracking, summation, 3D image, segmentation, and better imaging of the choroid. It provides the better structural information of retina and also the better understanding of pathologies. It allows more precise quantitative measurements of retinal thickness, more accurate follow-up of DME and assessment of treatment efficacy. So it plays an important role in clinical applications. SD-OCT continues progressing. The prototypes of the ultrahigh-resolution OCT are already available. ultrahigh-resolution OCT allows the acquisition of an image with 2 µm resolution which is almost the resolution obtained by histopathology. So OCT prepares us still much more surprises in future. But we have time and still a lot of things to learn with SD-OCT. It is already a valuable tool in the decision-making process of DME treatment and it should always be used in monitoring the effect of therapies in clinical trials.